PharmaCyte Biotech, Inc. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q2 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q2 2014 to Q2 2024.
  • PharmaCyte Biotech, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending July 31, 2024 was $23.4M.
  • PharmaCyte Biotech, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending July 31, 2024 was $26.9M.
  • PharmaCyte Biotech, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was $333K.
  • PharmaCyte Biotech, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was -$4.32M, a 2.1% decline from 2021.
  • PharmaCyte Biotech, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -$4.23M, a 19.3% decline from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $26.9M $23.4M +$26.6M May 1, 2024 Jul 31, 2024 10-Q 2024-09-17
Q1 2024 $333K $1.35M +$1.48M Feb 1, 2024 Apr 30, 2024 10-K 2024-08-13
Q4 2023 -$1.14M -$618K +$148K +19.3% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 -$1.29M $2.79M +$4.67M Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-15
Q2 2023 -$5.96M -$3.18M -$1.64M -106% May 1, 2023 Jul 31, 2023 10-Q 2024-09-17
Q1 2023 -$4.32M -$132K +$1.29M +90.7% Feb 1, 2023 Apr 30, 2023 10-K 2024-08-13
Q4 2022 -$5.61M -$767K +$44.8K +5.52% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 -$5.66M -$1.88M -$904K -92.6% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 -$4.75M -$1.54M -$517K -50.3% May 1, 2022 Jul 31, 2022 10-Q 2023-09-18
Q1 2022 -$4.23M -$1.42M -$454K -47.1% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-31
Q4 2021 -$3.78M -$812K -$55.3K -7.31% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-16
Q3 2021 -$3.73M -$977K -$29.5K -3.11% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-14
Q2 2021 -$3.7M -$1.03M -$146K -16.5% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q1 2021 -$3.55M -$965K -$214K -28.6% Feb 1, 2021 Apr 30, 2021 10-K 2022-07-28
Q4 2020 -$3.34M -$756K +$120K +13.7% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 -$3.46M -$947K +$120K +11.2% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-14
Q2 2020 -$3.58M -$881K +$260K +22.8% May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q1 2020 -$3.83M -$751K +$394K +34.4% Feb 1, 2020 Apr 30, 2020 10-K 2021-08-10
Q4 2019 -$4.23M -$876K -$203K -30.2% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-12
Q3 2019 -$4.03M -$1.07M -$24.6K -2.36% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-11
Q2 2019 -$4M -$1.14M +$75.7K +6.22% May 1, 2019 Jul 31, 2019 10-Q 2020-09-11
Q1 2019 -$4.08M -$1.14M +$155K +11.9% Feb 1, 2019 Apr 30, 2019 10-K 2020-08-13
Q4 2018 -$4.23M -$673K +$1.36M +66.9% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-13
Q3 2018 -$5.59M -$1.04M +$771K +42.5% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-23
Q2 2018 -$6.36M -$1.22M +$473K +28% May 1, 2018 Jul 31, 2018 10-Q 2019-09-13
Q1 2018 -$6.84M -$1.3M -$146K -12.7% Feb 1, 2018 Apr 30, 2018 10-K 2019-08-13
Q4 2017 -$6.69M -$2.03M -$750K -58.5% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-14
Q3 2017 -$5.94M -$1.81M -$839K -86.1% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-14
Q2 2017 -$5.1M -$1.69M -$657K -63.6% May 1, 2017 Jul 31, 2017 10-Q 2018-09-12
Q1 2017 -$4.44M -$1.15M -$31.5K -2.81% Feb 1, 2017 Apr 30, 2017 10-K 2018-07-20
Q4 2016 -$4.41M -$1.28M +$509K +28.4% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 -$4.92M -$975K +$661K +40.4% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-14
Q2 2016 -$5.58M -$1.03M +$483K +31.9% May 1, 2016 Jul 31, 2016 10-Q 2017-09-13
Q1 2016 -$6.06M -$1.12M +$1.7M +60.2% Feb 1, 2016 Apr 30, 2016 10-K 2017-07-27
Q4 2015 -$7.76M -$1.79M -$333K -22.8% Nov 1, 2015 Jan 31, 2016 10-Q/A 2017-03-13
Q3 2015 -$7.43M -$1.64M +$2.43M +59.8% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-02
Q2 2015 -$9.86M -$1.52M +$68.2K +4.3% May 1, 2015 Jul 31, 2015 10-Q 2016-09-06
Q1 2015 -$9.93M -$2.82M Feb 1, 2015 Apr 30, 2015 10-K 2016-07-29
Q4 2014 -$1.46M Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-08
Q3 2014 -$4.06M Aug 1, 2014 Oct 31, 2014 10-Q/A 2016-01-19
Q2 2014 -$1.58M May 1, 2014 Jul 31, 2014 10-Q/A 2016-01-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.